Serveur d'exploration SRAS - Curation (Ncbi)

Index « Keywords » - entrée « Drug Resistance, Viral »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Resistance, Microbial < Drug Resistance, Viral < Drug Resistance, Viral (drug effects)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000483 (2003) Xiang Xu [République populaire de Chine] ; Yunqing Liu ; Susan Weiss ; Eddy Arnold ; Stefan G. Sarafianos ; Jianping DingMolecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design.
000520 (2004) John Oxford [Royaume-Uni] ; Shobana Balasingam [Royaume-Uni] ; Rob Lambkin [Royaume-Uni]A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community
000B18 (2003) J S Oxford [Royaume-Uni] ; A. Mann ; R. LambkinA designer drug against influenza: the NA inhibitor oseltamivir (Tamiflu).
001056 (2005) Benjamin W. Neuman [États-Unis] ; David A. Stein ; Andrew D. Kroeker ; Michael J. Churchill ; Alice M. Kim ; Peter Kuhn ; Philip Dawson ; Hong M. Moulton ; Richard K. Bestwick ; Patrick L. Iversen ; Michael J. BuchmeierInhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers.
001256 (2005) Caterina Fattorusso [Italie] ; Sandra Gemma ; Stefania Butini ; Paul Huleatt ; Bruno Catalanotti ; Marco Persico ; Meri De Angelis ; Isabella Fiorini ; Vito Nacci ; Anna Ramunno ; Manuela Rodriquez ; Giovanni Greco ; Ettore Novellino ; Alberto Bergamini ; Stefano Marini ; Massimo Coletta ; Giovanni Maga ; Silvio Spadari ; Giuseppe CampianiSpecific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
001516 (2006) Shiro Shigeta [Japon] ; Shuichi Mori ; Toshihiro Yamase ; Norio Yamamoto ; Naoki YamamotoAnti-RNA virus activity of polyoxometalates.
001526 (2006) Rakesh Kumar [Canada] ; Wassila Semaine ; Monika Johar ; D Lorne J. Tyrrell ; Babita AgrawalEffect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
001610 (2006) George E. ParrisAIDS: Caused by development of resistance to drugs in a non-target intracellular parasite
001896 (2007) Jan Balzarini [Belgique]Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?
001A46 (2007) Marc G. Wathelet ; Melissa Orr ; Matthew B. Frieman ; Ralph S. BaricSevere Acute Respiratory Syndrome Coronavirus Evades Antiviral Signaling: Role of nsp1 and Rational Design of an Attenuated Strain▿
001D73 (2009) Andrea Spallarossa [Italie] ; Sara Cesarini ; Angelo Ranise ; Olga Bruno ; Silvia Schenone ; Paolo La Colla ; Gabriella Collu ; Giuseppina Sanna ; Barbara Secci ; Roberta LoddoNovel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors.
001D97 (2009) Jeffrey Anderson [États-Unis] ; Celia Schiffer ; Sook-Kyung Lee ; Ronald SwanstromViral protease inhibitors.
002253 (2010) James B. Mahony [Canada]Nucleic acid amplification-based diagnosis of respiratory virus infections.
002431 (????) James B. Mahony [Canada] ; Astrid Petrich ; Marek SmiejaMolecular diagnosis of respiratory virus infections.
002937 (2014) Xufang Deng [États-Unis] ; Sarah E. Stjohn [États-Unis] ; Heather L. Osswald [États-Unis] ; Amornrat O'Brien [États-Unis] ; Bridget S. Banach [États-Unis] ; Katrina Sleeman [États-Unis] ; Arun K. Ghosh [États-Unis] ; Andrew D. Mesecar [États-Unis] ; Susan C. Baker [États-Unis]Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance.
002C00 (2016) Jennifer L. Mckimm-Breschkin [Australie] ; Alicia M. Fry [États-Unis]Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
002D01 (2016) Li-Qiang Sun ; Eric Mull ; Barbara Zheng ; Stanley D'Andrea ; Qian Zhao ; Alan Xiangdong Wang ; Ny Sin ; Brian L. Venables ; Sing-Yuen Sit ; Yan Chen ; Jie Chen ; Anthony Cocuzza ; Donna M. Bilder ; Arvind Mathur [États-Unis] ; Richard Rampulla [États-Unis] ; Bang-Chi Chen [États-Unis] ; Theerthagiri Palani [Inde] ; Sivakumar Ganesan [Inde] ; Pirama Nayagam Arunachalam [Inde] ; Paul Falk ; Steven Levine ; Chaoqun Chen ; Jacques Friborg ; Fei Yu ; Dennis Hernandez ; Amy K. Sheaffer ; Jay O. Knipe ; Yong-Hae Han ; Richard Schartman ; Maria Donoso ; Kathy Mosure ; Michael W. Sinz ; Tatyana Zvyaga ; Ramkumar Rajamani ; Kevin Kish ; Jeffrey Tredup ; Herbert E. Klei ; Qi Gao [États-Unis] ; Alicia Ng [États-Unis] ; Luciano Mueller ; Dennis M. Grasela ; Stephen Adams [États-Unis] ; James Loy ; Paul C. Levesque [États-Unis] ; Huabin Sun [États-Unis] ; Hong Shi [États-Unis] ; Lucy Sun [États-Unis] ; William Warner [États-Unis] ; Danshi Li [États-Unis] ; Jialong Zhu [États-Unis] ; Ying-Kai Wang ; Hua Fang ; Mark I. Cockett ; Nicholas A. Meanwell ; Fiona Mcphee ; Paul M. ScolaDiscovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing.
002E45 (2017) Woo-Jin Shin [États-Unis] ; Baik Lin Seong [Corée du Sud]Type II transmembrane serine proteases as potential target for anti-influenza drug discovery.
003854 (2020) Catherine S. Adamson [Royaume-Uni]Antiviral Agents: Discovery to Resistance.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Drug Resistance, Viral" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Drug Resistance, Viral" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Drug Resistance, Viral
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021